Selected research
Industry Research
Rosuvastatin Industry Research Report 2026
Market perspective
The global Rosuvastatin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Rosuvastatin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Rosuvastatin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Rosuvastatin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Rosuvastatin include Teva Pharmaceutical Industries, Shandong Bechem Chemicals, Nanjing Frochem Tech, Lianyungang Runzhong Pharmaceutical, Jingxin Pharm, Zhejiang Hisun Pharmaceutical, Changzhou Pharmaceutical Factory, MSN Laboratories and Lunan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Rosuvastatin market in terms of revenue (US$ million) and, where applicable, sales volume (W Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Rosuvastatin Market by Company
Teva Pharmaceutical Industries
Shandong Bechem Chemicals
Nanjing Frochem Tech
Lianyungang Runzhong Pharmaceutical
Jingxin Pharm
Zhejiang Hisun Pharmaceutical
Changzhou Pharmaceutical Factory
MSN Laboratories
Lunan Pharmaceutical
LGM Pharma
HEC Pharm
CTX Life Sciences
Cadila Pharmaceuticals
Bal Pharma
AstraZeneca
Rosuvastatin Segment by Type
Purity 98.0%
Purity 99.0%
Other
Rosuvastatin Segment by Application
Tablet
Capsule
Others
Rosuvastatin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rosuvastatin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rosuvastatin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rosuvastatin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Rosuvastatin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Rosuvastatin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Rosuvastatin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity 98.0%
- Purity 99.0%
- Other
Applications
- Tablet
- Capsule
- Others
Companies covered
- Teva Pharmaceutical Industries
- Shandong Bechem Chemicals
- Nanjing Frochem Tech
- Lianyungang Runzhong Pharmaceutical
- Jingxin Pharm
- Zhejiang Hisun Pharmaceutical
- Changzhou Pharmaceutical Factory
- MSN Laboratories
- Lunan Pharmaceutical
- LGM Pharma
- HEC Pharm
- CTX Life Sciences
- Cadila Pharmaceuticals
- Bal Pharma
- AstraZeneca
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Rosuvastatin Market Size (2021-2032)
- 2.2.2 Global Rosuvastatin Sales (2021-2032)
- 2.2.3 Global Rosuvastatin Market Average Price (2021-2032)
- 2.3 Rosuvastatin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity 98.0%
- 2.3.3 Purity 99.0%
- 2.3.4 Other
- 2.4 Rosuvastatin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Tablet
- 2.4.3 Capsule
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Rosuvastatin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Rosuvastatin Sales (W Tons) of Manufacturers (2021-2026)
- 3.3 Global Rosuvastatin Revenue of Manufacturers (2021-2026)
- 3.4 Global Rosuvastatin Average Price by Manufacturers (2021-2026)
- 3.5 Global Rosuvastatin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Rosuvastatin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Rosuvastatin, Product Type & Application
- 3.8 Global Manufacturers of Rosuvastatin, Established Date
- 3.9 Global Rosuvastatin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical Industries
- 4.1.1 Teva Pharmaceutical Industries Company Information
- 4.1.2 Teva Pharmaceutical Industries Business Overview
- 4.1.3 Teva Pharmaceutical Industries Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Industries Rosuvastatin Product Portfolio
- 4.1.5 Teva Pharmaceutical Industries Recent Developments
- 4.2 Shandong Bechem Chemicals
- 4.2.1 Shandong Bechem Chemicals Company Information
- 4.2.2 Shandong Bechem Chemicals Business Overview
- 4.2.3 Shandong Bechem Chemicals Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shandong Bechem Chemicals Rosuvastatin Product Portfolio
- 4.2.5 Shandong Bechem Chemicals Recent Developments
- 4.3 Nanjing Frochem Tech
- 4.3.1 Nanjing Frochem Tech Company Information
- 4.3.2 Nanjing Frochem Tech Business Overview
- 4.3.3 Nanjing Frochem Tech Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Nanjing Frochem Tech Rosuvastatin Product Portfolio
- 4.3.5 Nanjing Frochem Tech Recent Developments
- 4.4 Lianyungang Runzhong Pharmaceutical
- 4.4.1 Lianyungang Runzhong Pharmaceutical Company Information
- 4.4.2 Lianyungang Runzhong Pharmaceutical Business Overview
- 4.4.3 Lianyungang Runzhong Pharmaceutical Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Lianyungang Runzhong Pharmaceutical Rosuvastatin Product Portfolio
- 4.4.5 Lianyungang Runzhong Pharmaceutical Recent Developments
- 4.5 Jingxin Pharm
- 4.5.1 Jingxin Pharm Company Information
- 4.5.2 Jingxin Pharm Business Overview
- 4.5.3 Jingxin Pharm Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Jingxin Pharm Rosuvastatin Product Portfolio
- 4.5.5 Jingxin Pharm Recent Developments
- 4.6 Zhejiang Hisun Pharmaceutical
- 4.6.1 Zhejiang Hisun Pharmaceutical Company Information
- 4.6.2 Zhejiang Hisun Pharmaceutical Business Overview
- 4.6.3 Zhejiang Hisun Pharmaceutical Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Zhejiang Hisun Pharmaceutical Rosuvastatin Product Portfolio
- 4.6.5 Zhejiang Hisun Pharmaceutical Recent Developments
- 4.7 Changzhou Pharmaceutical Factory
- 4.7.1 Changzhou Pharmaceutical Factory Company Information
- 4.7.2 Changzhou Pharmaceutical Factory Business Overview
- 4.7.3 Changzhou Pharmaceutical Factory Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Changzhou Pharmaceutical Factory Rosuvastatin Product Portfolio
- 4.7.5 Changzhou Pharmaceutical Factory Recent Developments
- 4.8 MSN Laboratories
- 4.8.1 MSN Laboratories Company Information
- 4.8.2 MSN Laboratories Business Overview
- 4.8.3 MSN Laboratories Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 MSN Laboratories Rosuvastatin Product Portfolio
- 4.8.5 MSN Laboratories Recent Developments
- 4.9 Lunan Pharmaceutical
- 4.9.1 Lunan Pharmaceutical Company Information
- 4.9.2 Lunan Pharmaceutical Business Overview
- 4.9.3 Lunan Pharmaceutical Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Lunan Pharmaceutical Rosuvastatin Product Portfolio
- 4.9.5 Lunan Pharmaceutical Recent Developments
- 4.10 LGM Pharma
- 4.10.1 LGM Pharma Company Information
- 4.10.2 LGM Pharma Business Overview
- 4.10.3 LGM Pharma Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 LGM Pharma Rosuvastatin Product Portfolio
- 4.10.5 LGM Pharma Recent Developments
- 4.11 HEC Pharm
- 4.11.1 HEC Pharm Company Information
- 4.11.2 HEC Pharm Business Overview
- 4.11.3 HEC Pharm Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 HEC Pharm Rosuvastatin Product Portfolio
- 4.11.5 HEC Pharm Recent Developments
- 4.12 CTX Life Sciences
- 4.12.1 CTX Life Sciences Company Information
- 4.12.2 CTX Life Sciences Business Overview
- 4.12.3 CTX Life Sciences Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 CTX Life Sciences Rosuvastatin Product Portfolio
- 4.12.5 CTX Life Sciences Recent Developments
- 4.13 Cadila Pharmaceuticals
- 4.13.1 Cadila Pharmaceuticals Company Information
- 4.13.2 Cadila Pharmaceuticals Business Overview
- 4.13.3 Cadila Pharmaceuticals Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Cadila Pharmaceuticals Rosuvastatin Product Portfolio
- 4.13.5 Cadila Pharmaceuticals Recent Developments
- 4.14 Bal Pharma
- 4.14.1 Bal Pharma Company Information
- 4.14.2 Bal Pharma Business Overview
- 4.14.3 Bal Pharma Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Bal Pharma Rosuvastatin Product Portfolio
- 4.14.5 Bal Pharma Recent Developments
- 4.15 AstraZeneca
- 4.15.1 AstraZeneca Company Information
- 4.15.2 AstraZeneca Business Overview
- 4.15.3 AstraZeneca Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 AstraZeneca Rosuvastatin Product Portfolio
- 4.15.5 AstraZeneca Recent Developments
5 Global Rosuvastatin Market Scenario by Region
- 5.1 Global Rosuvastatin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Rosuvastatin Sales by Region: 2021-2032
- 5.2.1 Global Rosuvastatin Sales by Region: 2021-2026
- 5.2.2 Global Rosuvastatin Sales by Region: 2027-2032
- 5.3 Global Rosuvastatin Revenue by Region: 2021-2032
- 5.3.1 Global Rosuvastatin Revenue by Region: 2021-2026
- 5.3.2 Global Rosuvastatin Revenue by Region: 2027-2032
- 5.4 North America Rosuvastatin Market Facts & Figures by Country
- 5.4.1 North America Rosuvastatin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Rosuvastatin Sales by Country (2021-2032)
- 5.4.3 North America Rosuvastatin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Rosuvastatin Market Facts & Figures by Country
- 5.5.1 Europe Rosuvastatin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Rosuvastatin Sales by Country (2021-2032)
- 5.5.3 Europe Rosuvastatin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Rosuvastatin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Rosuvastatin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Rosuvastatin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Rosuvastatin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Rosuvastatin Market Facts & Figures by Country
- 5.7.1 South America Rosuvastatin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Rosuvastatin Sales by Country (2021-2032)
- 5.7.3 South America Rosuvastatin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Rosuvastatin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Rosuvastatin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Rosuvastatin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Rosuvastatin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Rosuvastatin Sales by Type (2021-2032)
- 6.1.1 Global Rosuvastatin Sales by Type (2021-2032) & (W Tons)
- 6.1.2 Global Rosuvastatin Sales Market Share by Type (2021-2032)
- 6.2 Global Rosuvastatin Revenue by Type (2021-2032)
- 6.2.1 Global Rosuvastatin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Rosuvastatin Revenue Market Share by Type (2021-2032)
- 6.3 Global Rosuvastatin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Rosuvastatin Sales by Application (2021-2032)
- 7.1.1 Global Rosuvastatin Sales by Application (2021-2032) & (W Tons)
- 7.1.2 Global Rosuvastatin Sales Market Share by Application (2021-2032)
- 7.2 Global Rosuvastatin Revenue by Application (2021-2032)
- 7.2.1 Global Rosuvastatin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Rosuvastatin Revenue Market Share by Application (2021-2032)
- 7.3 Global Rosuvastatin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Rosuvastatin Value Chain Analysis
- 8.1.1 Rosuvastatin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Rosuvastatin Production Mode & Process
- 8.2 Rosuvastatin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Rosuvastatin Distributors
- 8.2.3 Rosuvastatin Customers
9 Global Rosuvastatin Analyzing Market Dynamics
- 9.1 Rosuvastatin Industry Trends
- 9.2 Rosuvastatin Industry Drivers
- 9.3 Rosuvastatin Industry Opportunities and Challenges
- 9.4 Rosuvastatin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst